President-elect Donald Trump described the drug industry as "disastrous" and criticized current industry practices during a press conference on Wednesday.
Supply Chain
Valeant Pharmaceuticals entered into two separate deals to sell off its oncology division and skin care unit for more than $2 billion, reports Bloomberg.
Sen. Chuck Grassley (R-Iowa), chairman of the Senate Judiciary Committee, hopes to achieve three major goals this year to help lower prescription drug prices.
Tideglusib, a drug previously used in Alzheimer's clinical trials, may boost the natural healing ability of teeth, according to a new study published in the journal Scientific Reports.
Amazon won a patent for a system to deliver packages through a network of underground tunnels, reports GeekWire.
United Postal Service acquired Freightex, a U.K.-based freight company, for an undisclosed amount on Jan. 3.
Amazon has increased use of robotics in its distribution centers by 50 percent since last year, reports the Seattle Times.
Len Schleifer, CEO of Regeneron Pharmaceuticals, criticized Thousand Oaks, Calif.-based Amgen for putting its own financial success ahead of patients, reports Reuters.
The Oklahoma Health Care Authority and the Oklahoma Department of Mental Health have collaborated to provide the opioid overdose reversal drug naloxone to youths 19 years old and younger in areas of the state with high rates of opioid abuse,…
St. Jude Medical, which Abbott Laboratories acquired in 2016, is releasing new cybersecurity updates for its implanted heart devices. The move comes five months after a government launched an investigation into the devices over claims they were vulnerable to dangerous…